Economic evaluation of temsirolimus on the basis of the results of the ARCC (Advanced Renal-Cell Carcinoma) study. (2009). Farmeconomia. Health Economics and Therapeutic Pathways, 10(2), 93-97. https://doi.org/10.7175/fe.v10i2.167